(Q45245260)

English

Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Michael J Kozal

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

R D MacArthur

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

L Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

G Peng

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

R M Novak

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

M van den Berg-Wolf

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

L Besch

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

T Yurik

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

B Schmetter

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

C Henley

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

M Dehlinger

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

CPRCA 058 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

361-370

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Abacavir hypersensitivity reaction

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1310%2FWEQG-QTHL-DL3X-FTXC

21 January 2018

Identifiers

10.1310/WEQG-QTHL-DL3X-FTXC

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15682349%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45245260&oldid=1584895541"